Target intelligence / Profile preview

RNA, U6 small nuclear 1279, pseudogene (RNU6-1279P)

Target
RNU6-1279P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 1279, pseudogene (RNU6-1279P) is a non-protein-coding RNA gene classified as a processed pseudogene. It is related to the U6 small nuclear RNA (snRNA), which is highly conserved and forms a core component of the spliceosome complex—the machinery responsible for removing introns from precursor mRNA during splicing. However, as a pseudogene, RNU6-1279P includes sequence changes or structural features that render it nonfunctional in the canonical RNA processing role of U6 snRNA. Like other pseudogenes, it is considered a genomic relic, derived by duplication or retrotransposition, and does not produce active RNA or protein products. There is no evidence it acts as a therapeutic target, nor are there links with drugs, disease biomarkers, or known safety issues associated with it. Key context: - Pseudogenes: Pseudogenes are DNA sequences that resemble functional genes but have lost their gene expression ability or protein-coding potential due to mutations, insertions, deletions, or premature stop codons. While some pseudogenes have been implicated in disease development and gene regulation through diverse mechanisms (such as acting as competitive endogenous RNAs or miRNA decoys), most, including RNU6-1279P, lack characterized specific functions or disease associations. - U6 snRNA background: The U6 snRNA is essential to the splicing of pre-mRNA and is highly conserved in evolution. Many U6 pseudogenes exist throughout the human genome as a result of gene duplication and retrotransposition. These pseudogenes typically do not contribute to RNA splicing or related biological processes.

Other names
RNU6-1279PRNA, U6 small nuclear 1279, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None established for this specific pseudogene; parental U6 snRNA genes are involved in pre-mRNA splicing, but pseudogenes typically lack direct biological function.
04

Disease associations

None established for this specific pseudogene; while a growing number of pseudogenes have been implicated in gene regulation and disease, there is currently no direct evidence for a role of RNU6-1279P in disease.
05

Safety considerations

None known; pseudogenes are generally not associated with direct therapeutic risk.
06

Interacting drugs

None reported
07

Biomarkers

None established

Beyond the preview

Go deeper on RNA, U6 small nuclear 1279, pseudogene (RNU6-1279P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1279, pseudogene (RNU6-1279P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call